Premium
LivaNova PLC (LIVN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-06-15 | Mr. Peter Marshall WilverIndependent Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 10,29k | - |
| 2026-06-15 | Mr. Peter Marshall WilverIndependent Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 10,29k | 52,78% |
| 2026-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 12,62k | - |
| 2026-06-15 | Mr. Todd Charles SchermerhornIndependent Non-Executive Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 12,62k | 39,24% |
| 2026-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,69k | 134,96k | Derivative Exercise and Sale | 79,70 - 80,19 | 9,58k | - |
| 2026-06-15 | Mr. Francesco BianchiIndependent Non-Executive Director | 2,36k | 0,00 | Derivative Exercise and Retained Stock | - | 9,58k | 32,60% |
| 2026-06-15 | Ms. Susan M. PodlogarIndependent Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 5,64k | - |
| 2026-06-15 | Mr. Donald J. ZurbayIndependent Director | 2,25k | 0,00 | Derivative Exercise and Retained Stock | - | 2,25k | - |
| 2026-06-15 | Mr. Donald J. ZurbayIndependent Director | -308,00 | 24,55k | Derivative Exercise and Sale | 79,70 | 2,25k | - |
| 2026-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 9,79k | 57,06% |
| 2026-06-15 | Ms. Brooke Elizabeth StoryIndependent Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 9,79k | - |
| 2026-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 15,31k | 30,26% |
| 2026-06-15 | Ms. Stacy Enxing SengIndependent Non-Executive Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 15,31k | - |
| 2026-06-15 | Mr. William A. KozyChairman of Board | 5,00k | 0,00 | Derivative Exercise and Retained Stock | - | 37,57k | 15,35% |
| 2026-06-15 | Mr. William A. KozyChairman of Board | -682,00 | 54,36k | Derivative Exercise and Sale | 79,70 | 37,57k | - |
| 2026-06-15 | Mr. Ahmet TezelChief Innovation Officer | 1,93k | 0,00 | Derivative Exercise and Retained Stock | - | 6,09k | 46,50% |
| 2026-06-15 | Mr. Ahmet TezelChief Innovation Officer | -1,03k | 82,25k | Derivative Exercise and Sale | 79,70 | 6,09k | - |
| 2026-06-15 | Mr. James Christopher BarryIndependent Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 7,92k | 81,52% |
| 2026-06-15 | Mr. James Christopher BarryIndependent Director | -486,00 | 38,73k | Derivative Exercise and Sale | 79,70 | 7,92k | - |
| 2026-06-15 | Ms. Susan M. PodlogarIndependent Director | 3,56k | 0,00 | Derivative Exercise and Retained Stock | - | 5,64k | 170,47% |
| 2026-05-26 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,80k | 136,35k | Vente | 75,75 | 7,23k | -19,94% |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | 2,22k | 0,00 | Derivative Exercise and Retained Stock | - | 4,16k | 114,83% |
| 2026-03-30 | Mr. Ahmet TezelChief Innovation Officer | -1,19k | 72,67k | Derivative Exercise and Sale | 61,27 | 4,16k | - |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | 9,44k | 0,00 | Derivative Exercise and Retained Stock | - | 22,19k | 74,02% |
| 2026-03-30 | Ms. Stephanie BoltonPresident of Global Epilepsy | -8,38k | 513,26k | Derivative Exercise and Sale | 61,27 | 22,19k | - |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | 5,02k | 0,00 | Derivative Exercise and Retained Stock | - | 5,02k | - |
| 2026-03-30 | Ms. Natalia KozminaChief HR Officer | -1,37k | 84,18k | Derivative Exercise and Sale | 61,27 | 5,02k | - |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | 9,88k | 0,00 | Derivative Exercise and Retained Stock | - | 14,17k | 230,70% |
| 2026-03-30 | Mr. Vladimir A. MakatsariaCEO & Director | -11,16k | 683,71k | Derivative Exercise and Sale | 61,27 | 14,17k | - |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | 17,97k | 0,00 | Derivative Exercise and Retained Stock | - | 44,65k | 67,34% |
| 2026-03-30 | Mr. Alex ShvartsburgCFO | -12,87k | 788,42k | Derivative Exercise and Sale | 61,27 | 44,65k | - |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 1,81k | 0,00 | Derivative Exercise and Retained Stock | - | 10,97k | 19,80% |
| 2026-03-30 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -1,37k | 83,94k | Derivative Exercise and Sale | 61,27 | 10,97k | - |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 91,00 | 5,24k | Derivative Exercise and Retained Stock | 57,60 | 9,16k | 1,00% |
| 2026-03-11 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -2,05k | 9,55k | Derivative Exercise and Sale | 57,60 - 62,26 | 9,16k | - |
| 2025-12-15 | Mr. Michael D. HutchinsonInitié | 1,13k | 0,00 | Derivative Exercise and Retained Stock | - | 6,80k | 19,98% |
| 2025-12-15 | Mr. Michael D. HutchinsonInitié | -1,12k | 70,75k | Derivative Exercise and Sale | 63,06 | 6,80k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | 2,09k | 0,00 | Derivative Exercise and Retained Stock | - | 2,09k | - |
| 2025-12-15 | Ms. Susan M. PodlogarIndependent Director | -269,00 | 16,96k | Derivative Exercise and Sale | 63,06 | 2,09k | - |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 551,00 | 0,00 | Derivative Exercise and Retained Stock | - | 9,07k | 6,47% |
| 2025-12-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -416,00 | 26,23k | Derivative Exercise and Sale | 63,06 | 9,07k | - |
| 2025-11-18 | Ms. Brooke Elizabeth StoryIndependent Director | -250,00 | 13,49k | Vente | 53,94 | 6,23k | -3,86% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | 366,00 | 0,00 | Derivative Exercise and Retained Stock | - | 8,52k | 4,49% |
| 2025-09-15 | Mr. Franco PolettiPresident of Cardiopulmonary Business Unit | -277,00 | 15,35k | Derivative Exercise and Sale | 55,43 | 8,52k | - |
| 2025-08-25 | Mr. Francesco BianchiIndependent Non-Executive Director | -1,50k | 84,75k | Vente | 56,50 | 9,03k | -14,25% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
